Skip to content

    Max India Ltd

    MAXIND
    Financial Services·7 Feb 2025
    Management Summary

    Max India Ltd reported a mixed Q3 FY25, with strong growth in its Antara Assisted Care and AGEasy segments, driven by successful new launches and increased bed capacity. However, consolidated revenues were down 18% due to cyclical collection patterns in the senior living residences, and the company reported an increased EBITDA loss as it invests for growth. Management remains committed to its long-term revenue and profitability targets, actively pursuing new community developments and strategic partnerships.

    Highlights

    5
    • Antara Senior Living (Gurgaon) saw phenomenal response, selling 82% of 292 units (240 units) within a few months.

    • Dehradun community reported operational revenue of ₹6.1 crores for Q3 FY25, a 13% growth YoY, and became operationally cash positive with a cash surplus of ₹110 crores.

    • Noida Phase-1 achieved 99% collection efficiency, with total collections of ₹382 crores, a 14% growth over last year.

    • Antara Assisted Care's overall net revenue grew 57% sequentially to ₹19.4 crores in Q3 FY25, marking a 176% YoY growth.

    • AGEasy recorded its highest-ever net revenue of ₹12.7 crores, a 92% growth over Q2 FY25, with monthly revenue rate growing from ₹52 lakhs in June to ₹3 crores in December.

    Concerns

    3
    • Consolidated revenues were ₹39 crores, 18% lower, primarily due to cyclical lower collections in residences.

    • Noida Phase-2 faced a temporary setback and delay in RERA approvals.

    • Consolidated EBITDA loss stood at ₹24.7 crores in Q3 FY25, compared to ₹15.7 crores in Q2 FY25, attributed to growth investments.

    What Changed2

    vs Q4 FY25

    Guidance items10 → 14 (+4)Risks discussed2 → 4 (+2)

    Key financials

    Single quarter

    06 metrics
    1. 01Consolidated Revenue₹39 Cr-18%QoQ
    2. 02Consolidated EBITDA Loss₹-24.7 Cr
    3. 03Antara Assisted Care Net Revenue₹19.4 Cr+1.8%YoY
    4. 04Care Home Net Revenue₹2.1 Cr+40%YoY
    5. 05Care Home Margin18%

    Segment breakdown

    Antara Senior Living (Real Estate)
    ₹6.1 Cr Dehradun Operational Revenue₹0.4 Cr Dehradun Profit₹382 Cr Noida Phase-1 Total Collection
    Antara Assisted Care
    ₹19.4 Cr Overall Net Revenue
    Care Homes
    ₹2.1 Cr Net Revenue100% Contribution Margin18% Margin (Q3 FY25)12% Margin (Q3 FY24)
    Care at Home
    ₹4.6 Cr Net Revenue17% Bangalore Sequential Growth7.0% Chennai Sequential Growth
    AGEasy
    ₹12.7 Cr Net Revenue₹3 Cr Monthly Revenue Rate (Dec)₹1.3 Cr Monthly Revenue Rate (Sep)₹0.52 Cr Monthly Revenue Rate (June)
    List

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Liquidity

    Liquidity disclosed

    Overall treasury and other monetizable asset stand at Rs. 312 crores as of December 24.

    Guidance & targets

    14
    CategoryTargetPriority
    Community Development
    New communities created
    8-10 communities
    High
    Community Development
    New community square feet
    1.5 million square feet
    High
    AGEasy Gross Margin
    Gross Margin
    55%-60%
    High
    AGEasy Gross Margin
    Gross Margin
    60% plus
    High
    AGEasy Profitability
    CM2 Positive
    CM2 positive
    High
    AGEasy Revenue
    Business Size
    ₹500 crores
    High
    Company Revenue
    Total Revenue
    ₹1,000 crores
    High
    Company Breakeven
    Consolidated Breakeven
    Breakeven
    High
    Care Home Annual Revenue
    Annual Revenue per Care Home
    ₹5-6 crores
    Medium
    AGEasy Channel Mix
    Marketplace vs D2C vs Offline
    50:40:10
    Medium
    Antara Consolidated Targets
    Topline
    ₹250 crores
    High
    Antara Consolidated Targets
    EBITDA Margin
    Healthy EBITDA margin
    Medium
    Antara Consolidated Targets
    Total Revenue
    ₹1,000 crores
    High
    Antara Consolidated Targets
    Assisted Living Bed Capacity
    1500-2000 beds
    High

    Noida Phase-2 RERA approval status

    next quarter
    CurrentTemporary setback, discussions underway with appellate authority
    TargetResolution of RERA issues and approval for Phase-2

    Why it matters

    Resolution of RERA issues is key to launching Noida Phase-2 and realizing its revenue potential.

    The application for OC has been kept in abeyance by Noida as some of you are aware, there is a sector 150 issues being sorted out and the Noida authority is waiting for direction from the Government. On Phase-2 of Noida sector 150, in the last earnings calls I had informed you that we had temporary set back because of RERA. We have now taken this up with appellate authority and resolution discussions are underway for these approvals.

    How to verify

    risks_and_concerns[risk='Noida Phase-2 RERA approval delays'].detail

    Risks & concerns

    4
    RiskSeverity

    Noida Phase-2 RERA approval delays

    Application for OC kept in abeyance due to sector 150 issues, leading to a temporary setback and delay in Phase-2 launch.Management acknowledged

    medium

    Cyclical nature of residence collections impacting consolidated revenue

    Consolidated revenue was 18% lower primarily due to lower collections in residences, which is a temporary cyclical phenomenon.Management acknowledged

    medium

    Occupancy issues in Gurgaon Care Home

    Gurgaon Care Home experienced some occupancy issues due to a lack of long-term move-ins, though contribution margins remained steady.Management acknowledged

    low

    Increased consolidated EBITDA loss due to growth investments

    Consolidated EBITDA loss increased to ₹24.7 crores from ₹15.7 crores in Q2 FY25, as the company is a growth business requiring investment.Management acknowledged

    medium

    Q&A highlights

    8

    “So, I think on a gross margin business, that is the first, we should look at about 55%-60% range next year, right, and a two-year timeframe, 60% plus, right? That is what we should look at. And CM2 positive, we want to be in two years, we should be CM2 positive as well, which is including all your direct spend.”

    Clarifies the company's specific margin targets and profitability milestones for the AGEasy segment, indicating a clear path to improved financial performance.

    asked by Harsh Kundnani

    3 min read6 chapters

    Detailed Narrative

    01

    Q3 FY25 Performance Overview and Strategic Focus

    Max India reported an action-packed Q3 FY25 with steady progress across all business verticals. Consolidated revenues for the quarter were ₹39 crores, an 18% decrease, primarily attributed to cyclical lower collections in residences. Despite this, the company maintained a strong treasury and other monetizable asset base of ₹312 crores as of December 24, with a consolidated net worth of ₹400 crores. Management emphasized its commitment to building an integrated care ecosystem for seniors, leveraging its unique lineage in healthcare, real estate, and hospitality.

    02

    Antara Senior Living (Real Estate) Developments

    The first intergenerational living community in Gurgaon saw a phenomenal response, with 82% of its 292 units (240 units) sold within a few months. This success has prompted discussions for a Phase-2 partnership in Gurgaon. The Dehradun community's operational revenue grew 13% YoY to ₹6.1 crores in Q3 FY25, achieving operational cash positivity and a cash surplus of ₹110 crores. Noida Phase-1 achieved 99% collection efficiency, with ₹382 crores collected, marking a 14% growth YoY, and is on track for possession. However, Noida Phase-2 faces a temporary setback📎 due to RERA approval delays.

    03

    Antara Assisted Care (Care Homes & Care at Home) Expansion

    Antara Assisted Care's overall net revenue surged 57% sequentially to ₹19.4 crores in Q3 FY25, representing a 176% YoY growth. The company added 234 new beds in Care Homes in the current fiscal year, increasing total capacity to 300 beds, with plans for an additional 200 beds in Chennai and Bangalore to be operational in Q4 FY25. Care Homes reported net revenue of ₹2.1 crores (up 22% QoQ, 40% YoY) and saw margins improve significantly from 12% in Q3 FY24 to 18% in Q3 FY25. Care at Home also reported healthy revenues, with Bangalore growing 17% and Chennai 7% sequentially.

    04

    AGEasy (Products & Services) Growth and Strategy

    AGEasy, including the erstwhile MedCare business, achieved its highest-ever net revenue of ₹12.7 crores, growing 92% over Q2 FY25. Its monthly revenue rate escalated from ₹52 lakhs in June to ₹3 crores in December. The product portfolio expanded to over 60 products and 180 SKUs, with a strong focus on senior-specific features. The company aims for AGEasy to reach ₹500 crores in revenue within five years and targets gross margins of 55-60% next year, improving to over 60% within two years, with a goal of becoming CM2 positive in two years.

    05

    Strategic Partnerships and Product Innovation

    Max India forged several strategic partnerships to enhance its offerings and reach. Collaborations include IIT Delhi for product innovations, Boat for tech-led solutions in wearables and hearables, Dr. Lal PathLabs for customized geriatric packages, and Well-being Nutrition for nutraceuticals. The company is also partnering with Axis Bank for its 'Silver Lining' program to access a large customer base of seniors and with Axis Max Life Insurance for annuity plans. Sourcing from China for 20 products, valued at ₹5 crores, is expected to improve margins by 20%.

    06

    Financial Outlook and Capital Strategy

    Management reiterated its ambition to achieve ₹1,000 crores in revenue for the overall company within the next five years and expects to reach consolidated breakeven by FY27-FY28. The company is actively pursuing opportunities to create 1.5 million square feet of new communities annually, focusing on financially attractive projects like Gurgaon Phase-2 and Chandigarh. While the company is seeking growth capital for both Antara Assisted Care and AGEasy, the equity dilution process is expected to take 6-9 months, with the rights issue potentially at the holding company level and subsidiary-level funding for $10-12 million.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.